Arovella Therapeutics Ltd
(ASX) ALA
Arovella Therapeutics Ltd Financials at a Glance
Market Cap
$86.92M
Revenue (TTM)
$144.50K
Net Income (TTM)
$14.19M
EPS (TTM)
$-0.01
P/E Ratio
-10.29
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.09
Volume
4,802,877
Open
$0.07
Price
$0.09
Volume
4,802,877
Open
$0.07
Previous Close
$0.09
Daily Range
$0.07 - $0.09
52-Week Range
$0.07 - $0.13
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.09
Volume
4,802,877
Open
$0.07
Previous Close
$0.09
Daily Range
$0.07 - $0.09
52-Week Range
$0.07 - $0.13
ALA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arovella Therapeutics Ltd
Industry
Pharmaceuticals
Sector
Health CareCEO
Michael Baker, PhD, MBA
Website
www.arovella.comHeadquarters
Osborne Park, WA 6017, AU
ALA Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
5%
Net Income Margin
2%
Return on Equity
-52%
Return on Capital
-84%
Return on Assets
-39%
Earnings Yield
-9.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$86.92M
Shares Outstanding
1.21B
Volume
4.80M
Short Interest
0.00%
Avg. Volume
940.84K
Financials (TTM)
Gross Profit
$136.00K
Operating Income
$11.20M
EBITDA
$11.10M
Operating Cash Flow
$6.93M
Capital Expenditure
$412.90K
Free Cash Flow
$7.34M
Cash & ST Invst.
$20.88M
Total Debt
$0.00
Arovella Therapeutics Ltd Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$59.15K
+96.0%
Gross Margin
0.00%
N/A
Market Cap
$86.92M
N/A
Market Cap/Employee
$3.22M
N/A
Employees
27
N/A
Net Income
$1.88M
+52.4%
EBITDA
$5.44M
+7.1%
Quarterly Fundamentals
Net Cash
$19.37M
+306.6%
Accounts Receivable
$126.45K
+13.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-39.15%
N/A
Return on Invested Capital
-83.85%
N/A
Free Cash Flow
$1.76M
+34.4%
Operating Cash Flow
$1.71M
+35.3%